M. French

P. Price, M. French, L. Abraham, 2003, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Systemic lupus erythematosus and Klinefelter's syndrome.

M. French, P. Hughes, 1983, Annals of the rheumatic diseases.

Systemic lupus erythematosus andKlinefelter's syndrome

M. French, 1983 .

Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial

M. Plana, A. Landay, Jacqueline Neuhaus, 2011, AIDS.

Antibody and B-cell responses may control circulating lipopolysaccharide in patients with HIV infection

S. Lewin, D. Purcell, L. D'Orsogna, 2011, AIDS.

An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy

P. Price, M. French, S. F. Stone, 2001, Clinical and experimental immunology.

Persistent immune activation in chronic HIV infection: do any interventions work?

S. Lewin, R. Rajasuriar, M. French, 2013, AIDS.

CD4+ T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4+ T cells.

S. Lewin, D. Purcell, P. Price, 2011, The Journal of infectious diseases.

CD 4 1 T-Cell Deficiency in HIV Patients Responding to Antiretroviral Therapy Is Associated With Increased Expression of Interferon-Stimulated Genes in CD 4 1 T Cells

S. Lewin, D. Purcell, P. Price, 2011 .

Severity of infections in IgA deficiency: correlation with decreased serum antibodies to pneumococcal polysaccharides and decreased serum IgG2 and/or IgG4

M. French, J. Peter, R. Dawkins, 1995, Clinical and experimental immunology.

Immunoglobulin G subclass distribution of autoantibodies in systemic sclerosis, primary biliary cirrhosis, and overlap syndromes.

R. Bernstein, M. French, 1987, Annals of the rheumatic diseases.

Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis

I. James, P. Price, D. Tan, 2008, HIV medicine.

Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpesvirus-associated immune restoration disease after start of highly active antiretroviral therapy.

P. Price, M. French, J. Brochier, 2001, The Journal of infectious diseases.

Serum immune complexes in systemic sclerosis: relationship with precipitating nuclear antibodies.

C. Penning, M. French, P. Hughes, 1985, Annals of the rheumatic diseases.

CXCR4 or CCR5 tropism of human immunodeficiency virus type 1 isolates does not determine the immunological milieu in patients responding to antiretroviral therapy.

P. Price, P. Gorry, Silvia Lee, 2006, Viral immunology.

Immune restoration disease after antiretroviral therapy

P. Price, M. French, S. F. Stone, 2004, AIDS.

Lymphadenopathy and selective IgA deficiency.

M. French, 1984, British medical journal.

The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases

F. Christiansen, C. Witt, S. Mallal, 1999, Immunological reviews.

Cerebral mass lesions due to cytomegalovirus in patients with AIDS: report of two cases.

S. Mallal, M. French, J. Dyer, 1995, The Journal of infection.

Protein-losing enteropathy in systemic lupus erythematosus.

M. French, S. Edmunds, B. Beveridge, 1988, Australian and New Zealand journal of medicine.

Multiple pneumatocoeles and bilateral tension pneumothoraces complicating pneumocystis pneumonia in AIDS.

Q. Summers, M. French, R. Tarala, 1990, Australian and New Zealand journal of medicine.

Serum IgG subclass concentrations in healthy adults: a study using monoclonal antisera.

M. French, G. Harrison, 1984, Clinical and experimental immunology.

The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy.

P. Price, Silvia Lee, M. French, 2017, Clinical immunology.

Hepatitis C virus‐associated hepatitis following treatment of HIV‐infected patients with HIV protease inhibitors: an immune restoration disease?

M. French, J. Flexman, M. John, 1998, AIDS.

Pyomyositis complicating the acquired immunodeficiency syndrome: A report of two cases with coexistent neutropenia

M. French, R. Thomas, 1991, The Medical journal of Australia.

Immune reconstitution syndrome is not a single entity.

P. Price, M. French, A. Lim, 2008, AIDS.

Brief Communication: Immune Activation in Patients Infected with HIV Type 1 and Maintaining Suppression of Viral Replication by Highly Active Antiretroviral Therapy

P. Price, M. French, C. Almeida, 2002 .

Immune restoration disease: a consequence of dysregulated immune responses after HAART.

P. Price, M. French, S. F. Stone, 2004, Current HIV research.

HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study

S. Mallal, D. Cooper, M. Law, 2001, AIDS.

High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication.

M. Moroni, D. Cooper, P. Reiss, 1997, The Journal of infectious diseases.

Interferon-Gamma Responses to Candida Recover Slowly or Remain Low in Immunodeficient HIV Patients Responding to ART

J. Warmington, I. James, P. Price, 2006, Journal of Clinical Immunology.

Cytomegalovirus (CMV) retinitis immune restoration disease occurs during highly active antiretroviral therapy-induced restoration of CMV-specific immune responses within a predominant Th2 cytokine environment.

P. Price, M. French, M. Tay-Kearney, 2002, The Journal of infectious diseases.

Immune restoration disease in HIV patients: aberrant immune responses after antiretroviral therapy.

P. Price, M. French, 2002, Journal of HIV therapy.

A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study

D. Cooper, M. Law, S. Emery, 2000, AIDS.

Extensive Perianal and Anal Canal Intraepithelial Neoplasia (AIN) in an HIV Antibody Positive Male Treated with Combination Antiretroviral Therapy

M. French, J. Flexman, B. Latham, 2000 .

Thymic function in severely immunodeficient HIV type 1-infected patients receiving stable and effective antiretroviral therapy.

S. Lewin, P. Price, S. Fernandez, 2006, AIDS research and human retroviruses.

Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: the Australian AIDS cohort.

S. Mallal, J. Kaldor, D. Cooper, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Interferon-γ and IL-5 production correlate directly in HIV patients co-infected with mycobacterium tuberculosis with or without immune restoration disease.

P. Price, J. Elliott, M. French, 2010, AIDS research and human retroviruses.

MHC haplotypes affect the expression of opportunistic infections in HIV patients.

P. Price, M. French, K. Cheong, 2001, Human immunology.

Fusobacterium Nucleatum Hepatic Abscess with Pylephlebitis Associated with Idiopathic Cd4

P. Price, M. French, R. Murray, 2001 .

Serum IgG subclasses in patients with an increased susceptibility to respiratory tract infections.

M. French, G. Harrison, 1987, Australian and New Zealand journal of medicine.

Immunosenescent CD57+CD4+ T-cells Accumulate and Contribute to Interferon-γ Responses in HIV Patients Responding Stably to ART

P. Price, S. Fernandez, M. French, 2011, Disease markers.

An investigation into the effect of the IgG antibody system on the susceptibility of IgA-deficient patients to respiratory tract infections.

M. French, G. Harrison, 1986, Clinical and experimental immunology.

Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV‐1‐infected individuals

D. Cooper, C. Duncombe, M. French, 1998, AIDS.

MHC genes and HIV infection

S. Mallal, M. French, P. Cameron, 1990, The Lancet.

HIV and the acquired immunodeficiency syndrome

S. Wesselingh, M. French, 2009 .

Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations.

S. Mallal, M. French, P. Cameron, 1990, Human immunology.

Effects of IL‐2 therapy in asymptomatic HIV‐infected individuals on proliferative responses to mitogens, recall antigens and HIV‐related antigens

A. Kelleher, S. Emery, M. French, 1998, Clinical and experimental immunology.

Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease.

P. Price, M. French, S. F. Stone, 2006, The Journal of antimicrobial chemotherapy.

Graves' disease during immune reconstitution after highly active antiretroviral therapy for HIV infection: evidence of thymic dysfunction.

S. Lewin, P. Price, P. Leedman, 2004, AIDS research and human retroviruses.

Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: a randomized, controlled, multicenter study. Australian IL-2 Study Group.

G. Stewart, D. Cooper, S. Emery, 1998, The Journal of infectious diseases.

Hepatitis C virus genotype and HIV coinfection affect cytokine mRNA levels in unstimulated PBMC but do not shift the T1/T2 balance

P. Price, Silvia Lee, M. French, 2006, Immunology and cell biology.

Intrafamilial transmission of HIV-1 infection from individuals with unrecognized HIV-1 infection

J. Kaldor, B. Herring, D. Dwyer, 2003, AIDS.

Rates of combination antiretroviral treatment change in Australia, 1997–2000

C. Moore, S. Mallal, D. Cooper, 2002 .

Acoustic neuropathy associated with zalcitabine-induced peripheral neuropathy.

M. French, O. Martinez, 1993, AIDS.

Susceptibility to opportunistic infections in HIV‐infected patients with increased CD4 T‐cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells

P. Price, M. French, N. Keane, 2007, HIV medicine.

Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy.

J. Kaldor, D. Cooper, J. Elliott, 2009, The Journal of infectious diseases.

TB-IRIS After Initiation of Antiretroviral Therapy Is Associated With Expansion of Preexistent Th1 Responses Against Mycobacterium tuberculosis Antigens

K. Mayer, S. Solomon, C. Benson, 2013, Journal of acquired immune deficiency syndromes.

Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients.

P. Price, Silvia Lee, M. French, 2002, The Journal of infectious diseases.

Restoration of CD4 T‐cell responses to cytomegalovirus is short‐lived in severely immunodeficient HIV‐infected patients responding to highly active antiretroviral therapy

I. James, P. Price, M. French, 2004, HIV medicine.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis.

C. Penning, M. French, P. Hughes, 1984, Clinical and experimental immunology.

HIV patients on antiretroviral therapy have high frequencies of CD8 T cells specific for Immediate Early protein-1 of cytomegalovirus

P. Moss, N. Khan, P. Price, 2005, AIDS.

Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk?

M. John, S. Mallal, G. Watts, 2003, QJM : monthly journal of the Association of Physicians.

Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic lupus erythematosus.

C. Penning, M. French, P. Hughes, 1985, Journal of clinical & laboratory immunology.

Immunological markers predicting outcome in patients with hepatitis C treated with interferon‐α and ribavirin

P. Price, G. Jeffrey, Silvia Lee, 2002, Immunology and cell biology.

NEPHROTIC SYNDROME IN A PATIENT WITH IgA DEFICIENCY-ASSOCIATED MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS

M. French, B. Latham, M. John, 2000, Pathology.

Glomerulonephritis and IgA deficiency.

C. Brown, M. French, R. A. Coward, 1987, Clinical Nephrology.

Protein losing enteropathy due to systemic lupus erythematosus.

M. French, M. Wood, I. Foulds, 1984, Gut.

CD4+ and CD8+ T Cells Expressing FoxP3 in HIV-Infected Patients Are Phenotypically Distinct and Influenced by Disease Severity and Antiretroviral Therapy

P. Price, M. French, A. Lim, 2009, Journal of acquired immune deficiency syndromes.

Single Radial Immune Haemolysis (SRIH) Assay for the Measurement of Complement Fixing Antibodies

M. French, G. Harrison, 1985 .

Antibody-mediated control of HIV-1 infection through an alternative pathway.

M. French, 2019, AIDS.

Impaired function of regulatory T-cells in patients with chronic obstructive pulmonary disease (COPD).

P. Thompson, P. Price, Y. Moodley, 2014, Immunobiology.

Percentage of CD3+CD4-CD8-γδTCR- T Cells Is Increased by HIV Disease

P. Price, M. French, R. Krueger, 2001 .

Declining incidence and later occurrence of Kaposi's sarcoma among persons with AIDS in Australia: the Australian AIDS cohort

S. Mallal, J. Kaldor, D. Cooper, 1996, AIDS.

Immune activation in patients infected with HIV type 1 and maintaining suppression of viral replication by highly active antiretroviral therapy.

P. Price, M. French, C. Almeida, 2002, AIDS research and human retroviruses.

Serum Parathyroid Hormone Concentrations in Patients with HIV Infection

M. French, A. John, D. Mallon, 1995, Annals of clinical biochemistry.

Serumimmunecomplexes insystemic sclerosis: relationship withprecipitating nuclear antibodies

C. Penning, M. French, P. Hughes, 1985 .

Leiomyoma of the oesophagus in an HIV-infected patient.

M. French, D. Cameron, A. Kamiński, 2001, Australasian radiology.

High circulating levels of soluble CD30 correlate with impaired delayed-type hypersensitivity responses in HIV-infected patients.

M. John, P. Price, M. French, 1999, AIDS.

Highly active antiretroviral therapy

M. John, S. Mallal, P. Price, 1998, The Lancet.

The IgG4 subclass is associated with a low affinity antibody response to tetanus toxoid in man.

M. Devey, M. French, G. Harrison, 1985, Immunology.

Epidemiology of late presentation of HIV infection in Western Australia.

S. Mallal, S. Gillieatt, M. French, 1992, The Medical journal of Australia.

Carcinoma of the scrotum in a PUVA-treated patient: the need for diagnostic suspicion

M. French, G. Douce, J. Byrne, 1994 .

Plasma biomarkers in the prediction and diagnosis of tuberculosis-associated immune reconstitution inflammatory syndrome.

P. Price, J. Elliott, M. French, 2011, AIDS.

Quality Assessment Program for Genotypic Antiretroviral Testing Improves Detection of Drug Resistance Mutations

F. Christiansen, S. Emery, M. French, 2003, Journal of Clinical Microbiology.

Imbalanced effector and regulatory cytokine responses may underlie mycobacterial immune restoration disease

L. D'Orsogna, P. Price, M. French, 2008, AIDS research and therapy.

Increased plasma CXCL10 may be a marker of increased risk of immune restoration disease associated with nonviral pathogens.

H. Wand, P. Price, M. French, 2012, Journal of acquired immune deficiency syndromes.

Genetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5delta32 allele.

M. Churchill, D. Purcell, S. Wesselingh, 2006, Journal of virology.

3. When do patients present with HIV infection?

J. Kaldor, M. French, 1993, The Medical journal of Australia.

Randomised, Placebo-Controlled, Phase I/IIa Evaluation of the Safety and Immunogenicity of Fowlpox Virus Expressing HIV gag-pol and Interferon-? in HIV-1 Infected Subjects

A. Kelleher, S. Emery, R. Puls, 2005, Human vaccines.

Production of IgG2 Antibodies to Pneumococcal Polysaccharides After Vaccination of Treated HIV Patients May Be Augmented by IL-7Rα Signaling in ICOS+ Circulating T Follicular-Helper Cells

Laila N. Abudulai, S. Fernandez, M. French, 2019, Frontiers in Immunology.

Imbalanced effector and regulatory cytokine responses may underlie mycobacterial immune restoration disease

L. D'Orsogna, P. Price, M. French, 2008 .

Pulmonary Mycobacterium celatum immune restoration disease: immunopathology and response to corticosteroid therapy.

M. French, C. Heath, Helen Bell, 2005, AIDS.

A rare case of lues maligna with ocular involvement presenting as an unmasking immune reconstitution inflammatory syndrome in a patient with HIV infection

M. French, C. Vinciullo, Claire M. Italiano, 2018, The Australasian journal of dermatology.

Regulatory T cells are converts in simian immunodeficiency virus infection.

M. French, A. Kinter, 2012, AIDS.

Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy.

S. Lewin, K. Ruxrungtham, P. Price, 2009, The Journal of infectious diseases.

Syndemic synergy of HPV and other sexually transmitted pathogens in the development of high-grade anal squamous intraepithelial lesions

M. French, M. French, J. Flexman, 2017, Papillomavirus research.

Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapy.

M. John, P. Price, M. French, 2000, AIDS research and human retroviruses.

Factors Associated With Plasma IL-6 Levels During HIV Infection.

A. Phillips, J. Lundgren, M. Vjecha, 2015, Journal of Infectious Diseases.

Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome

S. Swaminathan, E. Shankar, B. Andrade, 2015, AIDS.

Antiretroviral therapy. Immune restoration disease in HIV-infected patients on HAART.

M. French, 1999, The AIDS reader.

Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals: a case–control analysis nested in a large clinical trial

M. Johnson, A. Landay, M. French, 2015, AIDS.

Early commencement of antiretroviral therapy in HIV patients from resource-limited countries may prevent the hazards of severe immunodeficiency.

M. French, 2010, AIDS.

Impaired Upregulation of the Costimulatory Molecules, CD27 and CD28, on CD4+ T Cells from HIV Patients Receiving ART Is Associated with Poor Proliferative Responses.

P. Price, M. French, Sara Tanaskovic, 2017, AIDS research and human retroviruses.

Immunological Responses to Antiretroviral Therapy

M. French, 2014 .